Show Summary Details
Page of

Nomenclature for Renal Replacement Therapy in Acute Kidney Injury 

Nomenclature for Renal Replacement Therapy in Acute Kidney Injury
Chapter:
Nomenclature for Renal Replacement Therapy in Acute Kidney Injury
Author(s):

Mauro Neri

, Jorge Cerdá

, Francesco Garzotto

, Gianluca Villa

, and Claudio Ronco

DOI:
10.1093/med/9780190225537.003.0003
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 02 December 2020

We describe the basic principles underlying RRT technologies and the application of those principles to direct patient care. The aim of this chapter is to focus on the basic aspects and applications of continuous renal replacement therapies (CRRT) that are most often utilized in the treatment of the critically ill patient with severe AKI. We provide a thorough description of the CRRT hardware and disposables; the procedure phases; the solutes and fluid transport mechanisms across membranes; and the different prescribing modalities.

To ensure a complete review of the RRT nomenclature utilized in the Intensive Care Unit (ICU), we screened the literature of the last 25 years and implemented previous taxonomy efforts. We completed an extensive literature search for papers published in English from Jan 1990 to date.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.